FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.
| Date | Drug | Type | Run-up 30d | Decision 1d | After 5d |
|---|---|---|---|---|---|
| 2026-01-31 | Anaphylm | NDA | -53.8% | +39% | +39.3% |
| 2025-11-06 | — | NDA | +0.5% | +2.2% | -7% |
| 2025-10-08 | Anaphylm | NDA | +19.2% | +3.9% | +15.2% |
A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for AQST and 2 more tickers of your choice.
Create Free Account →